2-(N-methyl)heptylamine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(N-methyl)heptylamine
• 英文别名: 2-methyl-1-heptylamine；2-methylheptan-1-amine；heptan-2-ylmethanamin；2-methylheptylamine
• 化学式: C₈H₁₉N
• 分子量: 129.246
• InChiKey: BHZFOIHRKRXWLL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  9
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-(N-methyl)heptylamine 在 4-二甲氨基吡啶 、 lithium hydroxide 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 54.0h， 生成 3-Methoxy-4-[1-methyl-5-(2-methyl-heptylcarbamoyl)-1H-indol-3-ylmethyl]-benzoic acid
  参考文献：
  名称：

  Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes

  摘要：

  Substituted indole-5-carboxamides and indole-6-carboxamides have been found to be potent and selective antagonists of the peptidoleukotrienes. Initial derivatives of these series (4-[[5-[(cyclopentylmethyl)carbamoyl]-1-methylindol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl] benzamide (5a) and 4-[[6-[(cyclopentylmethyl)carbamoyl]-3-methylindol-1-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide (6a), respectively), when compared to the corresponding indole amides (e.g. 28 and 29), were found to be approximately 10-fold less potent in vitro and substantially less active when administered orally to guinea pigs. Efforts to improve the potency of the title series by variation of the amide, indole, or sulfonamide substituents led to compounds of comparable in vitro potency to ICI 204,219, but of somewhat lower oral activity. A trend which suggested that more lipophilic transposed amides were needed to increase oral activity was exploited with some success and has led to the discovery of 5q (4-[[5-[(2-ethylbutyl)-carbamoyl]-1-ethylindol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]benzamide), a trans-posed amide with subnanomolar affinity for the leukotriene receptor and an oral ED50 of 5 mg/kg in a model of asthma in guinea pigs. In this model, ICI 204,219 was active at 0.4 mg/kg. The absolute bioavailability of 5q has been found to be 28% in the rat, as compared to 68% for ICI 204,219, with significant levels of 5q observed in the blood of rats up to 24 h postdose.

  DOI：

  10.1021/jm00055a011
• 作为产物：
  描述：

  N,N-dibenzyl-2-methylheptan-1-amine 在 palladium hydroxide, 20 wt% on carbon 、 氢气 作用下， 以 甲醇 为溶剂， 生成 2-(N-methyl)heptylamine
  参考文献：
  名称：

  1,1-二取代烯烃的对映选择性CuH催化抗马尔科夫尼科夫加氢胺化

  摘要：

  β-手性胺的对映选择性合成是通过铜催化的 1,1-二取代烯烃与羟胺酯在氢硅烷存在下的加氢胺化反应实现的。这种温和的方法以优异的收率和高对映选择性提供了一系列结构多样的 β-手性胺，包括 β-氘化胺。此外，可以采用低至 0.4 mol% 的催化剂负载量以不降低产率和选择性提供产品，证明了该方法用于大规模合成的实用性。

  DOI：

  10.1021/ja509786v

文献信息

• [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES, NUCLÉOTIDES SUBSTITUÉS ET LEURS ANALOGUES
  申请人：ALIOS BIOPHARMA INC

  公开号：WO2014209979A1

  公开（公告）日：2014-12-31

  Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a norovirus, with a nucleoside, a nucleotide and an analog thereof.

  本文揭示了核苷、核苷酸及其类似物，包括一个或多个核苷、核苷酸及其类似物的药物组合物，以及它们的合成方法。本文还揭示了利用核苷、核苷酸及其类似物改善和/或治疗疾病和/或病况的方法，包括使用核苷、核苷酸和其类似物治疗诺如病毒感染的方法。
• COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE
  申请人：Cameron Dale Russell

  公开号：US20080171783A1

  公开（公告）日：2008-07-17

  The present disclosure provides amide-based, non-nucleoside compounds having an inhibitory activity against endogenous polymerases, such as polymerase alpha and polymerase gamma. This disclosure further provides uses of treating hyperproliferative diseases or disorders, such as benign or malignant neoplasms, and more specifically cancers that are sensitive to inhibition of polymerase alpha and polymerase gamma.

  本公开提供了基于酰胺的非核苷类化合物，具有对内源聚合酶（如聚合酶α和聚合酶γ）的抑制活性。本公开进一步提供了用于治疗过度增殖性疾病或疾病的用途，例如良性或恶性肿瘤，更具体地是对聚合酶α和聚合酶γ抑制敏感的癌症。
• [EN] BCAT MODULATION<br/>[FR] MODULATION DE BCAT
  申请人：ICAGEN LLC

  公开号：WO2021007350A1

  公开（公告）日：2021-01-14

  This disclosure relates to, in part, the treatment of an organic acidemia in a subject in need thereof via administration of a therapeutically effective amount of compounds that inhibit BCAT2. The disclosure also relates to, in part, methods for identifying a candidate compound for treatment of organic acidemias.

  这份披露涉及部分通过给予抑制BCAT2的化合物的治疗有效量来治疗需要的受试者的有机酸血症。该披露还涉及部分用于识别治疗有机酸血症的候选化合物的方法。
• HYDROPHILIC SILICON-RHODAMINE FLUORESCENT PROBES AND USE THEREOF
  申请人：AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

  公开号：US20200340920A1

  公开（公告）日：2020-10-29

  The present invention relates to a novel near-infrared fluorescent probe having specificity for mitochondria due to a hydrophobic group attached to a silicon-rhodamine core, and the use thereof for mitochondrial detection and cancer diagnosis. The fluorescent probe of the present invention has improved mitochondrial targeting efficiency compared to conventional probes due to a hydrophobic group attached to a silicon-rhodamine core, can detect mitochondria in living tissue with high sensitivity and specificity in a near-infrared (NIR) region (700 to 1,700 nm), and can acquire three-dimensional high-resolution biological images without harming the human body. Due to these advantages, the fluorescent probe can be used not only for mitochondrial detection in cells in the laboratory, but also as a contrast agent or a drug delivery carrier in cancer diagnosis and surgery.

  本发明涉及一种新型近红外荧光探针，由于硅-罗丹明核上附着了疏水基团，具有对线粒体的特异性，并且可以用于线粒体检测和癌症诊断。与传统探针相比，本发明的荧光探针由于硅-罗丹明核上附着了疏水基团，具有改善的线粒体靶向效率，可以在近红外（NIR）区域（700至1,700纳米）高灵敏度、高特异性地检测活体组织中的线粒体，并能够在不伤害人体的情况下获取三维高分辨率生物图像。由于这些优点，荧光探针不仅可以用于实验室中细胞的线粒体检测，还可以作为癌症诊断和手术中的对比剂或药物输送载体。
• 一种异硫氰酸酯和磷氮硫系阻燃剂的联合制 备方法
  申请人：石家庄学院

  公开号：CN109734679B

  公开（公告）日：2022-04-05

  本发明公开了一种异硫氰酸酯类化合物和磷氮硫系阻燃剂的联合制备方法，所述方法是以胺和CS2为原料，在碱的作用下在溶剂中反应生成二硫代氨基甲酸盐，再与新戊二醇磷酰氯作用，制备异硫氰酸酯类化合物（I）。副产物l，3，2‑二氧磷杂环己烷硫代磷酸盐（II)经酸化，再与三聚氰胺在溶剂中反应成盐，制备磷氮硫系阻燃剂（III）。本发明提供的方法，可以联合制备异硫氰酸酯和磷氮硫系阻燃剂，操作简便，产品收率高，原子经济。制备的磷氮硫系阻燃剂（Ⅲ）阻燃效果好。